[DIV28SUPER] unsubscribe

Roxy And Vic
roxyandvic@netscape.netun

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 join our network

[DIV28SUPER] NIDA Neuroscience Update, June 26, 2013

Table of Contents

I.                     Hold the Date for Frontiers in Addiction Research Mini-convention , Nov 8, 2013, The Westin Hotel in the Gas Lamp Quarter in San Diego

II           Awards Announced for Discovering New Therapeutic Uses for Existing Molecules

III.                Short Course on the Genetics of Addiction

-------------------

 

 

I.                    Hold the Date for Frontiers in Addiction Research Mini-convention , Nov 8, 2013, The Westin Hotel in the Gas Lamp Quarter in San Diego

 

The NIDA Neuroscience Consortium would like to announce our plan (pending official approvals) to hold the Frontiers in Addiction Research Mini-convention as a Satellite Session at the 2013 Society for Neuroscience annual meeting.  As in past years, this meeting will provide the opportunity for you to interact with respected scientists across diverse disciplines as they describe the latest findings and discuss future directions in research related to the neuroscience of drug abuse and addiction.  The mini-convention is planned for Friday, November 8, 2013 at The Westin Hotel in the Gas Lamp Quarter in San Diego.  We plan to include several sessions aimed at discussing cutting edge research areas in neuroscience.  Please save the date. Once we receive the official approval to hold the meeting, we will disseminate detailed information via the meeting website.

 

The proposed sessions include: 

 

Emerging and Novel Aspects of Neuronal Transmission

Speakers: N.C. Spritzer, UCSD; D. L. Sabatini, Harvard; A. Wallén-Mackenzie, Uppsala University

 

Jacob P Waletzky Memorial Lecture

Speaker: The winner of the Jacob P. Waletzky Award and speaker will be announced at the mini-convention

 

Extracellular RNAs in Neuroscience:  Biology, Biomarkers, and Therapeutics

Speakers: X. Breakefield, MGH; C. Wahlestedt, U. Miami; P. Kenny, Scripps FL; M. Wood, U of Oxford

 

Advances in High Resolution and Large Scale Imaging of Brain Networks and Circuits

Speakers: K. Deisseroth, Stanford; R. Buckner, MGH; M. Schnitzer, Stanford; J. Donoghue, Brown University

 

Role of the Basal Ganglia in Addiction

Speakers: M.K. Lobo, U of Maryland; A. Kreitzer, Gladstone; S. Ferguson, U of Washington; R. Costa, NIAAA

 

For additional information please contact Mary Kautz, Ph.D. (kautzm@mail.nih.gov) or Cathrine Sasek, Ph.D. (csasek@nih.gov).

 --------------------------

 

II.                  Awards Announced for Discovering New Therapeutic Uses for Existing Molecules

This morning, NCATS announced the first awards for its Discovering New Therapeutic Uses for Existing Molecules program. With funding from the Common Fund, NIH has awarded $12.7 million to match nine academic research groups with a selection of pharmaceutical industry compounds to explore new treatments for patients in eight disease areas, including Alzheimer's disease, Duchenne muscular dystrophy and schizophrenia.

To learn more:

 

• Read the NIH news release
• View the project awards
• Watch videos about the program and projects
• Listen to audio clips about the projects
• Visit the New Therapeutic Uses webpage

 

--------------------------------------------

III.                Short Course on the Genetics of Addiction

August 17 – 22, 2013

 

This course emphasizes genetic applications and approaches to drug addiction research through methodological instruction based on literature, data sets and informatics resources drawn from studies of addiction related phenotypes. The course includes plenary sessions on major progress in addiction genetics, and discussion sessions in which students present their work for discussion on applications of genetic methods. Students will leave the course able to design and interpret genetic and genomic studies of addiction as they relate to their specific research question, and will be able to make use of current bioinformatics resources to identify research resources and make use of public data sources in their own research.

 

Organizers:
Elissa J. Chesler, Ph.D., The Jackson Laboratory
John Macauley, Ph.D., The Jackson Laboratory
Abraham A. Palmer, Ph.D., University of Chicago
Wade Berrettini, M.D., Ph.D., University of Pennsylvania

 

Registration Fee:   $1,650.00

·         Registration fee includes course materials, most meals and shared lodging.

Placement is limited to 35 attendees so early application is advised.

 

Limited scholarships will be available to help attendees with travel expenses.

To apply for this event or for more information, including schedule and speaker list, please visit:  http://courses.jax.org/2013/addiction.html

Or, contact Nancy Place at nancy.place@jax.org  or by telephone at 207-288-6257.

 

Applications by women, minorities, and persons with disabilities are strongly encouraged.

Funding for this conference was made possible (in part) by R13 DA 032192-03 from the National Institute on Drug Abuse and The Howard Hughes Medical Institute.

Nancy Place
Events & Meetings Planner
The Jackson Laboratory
600 Main Street
Bar Harbor, ME 04609-1500
Telephone - (207) 288-6257
Fax - (207) 288-6080
www.jax.org/courses/current.html

 

------------------------------------------------------------------------------------------------

 

The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services  TO UNSUBSCRIBE: send email to listserv@list.nih.gov<mailto:listserv@list.nih.  Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L   in the message body of the email - You will receive a confirmation email if successful. If you have problems contact jpollock@mail.nih.gov 301-435-1309

[DIV28SUPER] 28/50 CPA: Changing Addictive Behavior

 

The planning committee for the 2014 Collaborative Perspectives on Addiction

Conference is excited to announce the opening of our 2014 Call for Proposals

 

View the call for proposals at: www.tinyurl.com/2014CPACFP

 

·        Workshop Proposals

o   Due August 15, 2013

o   www.tinyurl.com/2014CPAWorkshops 

·        Breakout/Symposia Proposals

o   Due September 1, 2013

o   www.tinyurl.com/2014CPABreakout 

·        Poster Proposals

o   Priority Deadline: October 1, 2013

o   www.tinyurl.com/2014CPAPosters

 

ABOUT THE CONFERENCE

The theme for the 2014 conference is "Changing Addictive Behavior: Bench to Bedside and Back Again"

·         Atlanta, Georgia / February 28-March 1, 2014

·         Thought-provoking keynotes and cross-discipline panels

·         Interactive environment for collaboration/networking

·         Several breakout session choices

·         Poster Sessions

·         Pre-conference in-depth workshops

·         Discounted rates for Early Career Psychologists

·         Student opportunities (discounted rates, special networking, etc)

·         You don't have to be a member of either or division or APA to attend the conference!

·         CE is available!

 

 

ABOUT THE VENUE

The beautiful W Hotel in Midtown Atlanta will be the venue for the 2014 CPA. The hotel is located in the

heart of Midtown and is local to public transportation. Room rates are $159 per night. Reserve your room now!

 

MORE INFORMATION

Katie Witkiewitz, PhD, Co-Chair

Jennifer Buckman, PhD, Co-Chair

Chad Rummel, MEd, Registration and Hotel Accommodations (202-336-6121)

 

 

 

[DIV28SUPER] fda begins regulation of tobacco products

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm358421.htm

""..For the first time since the Family Smoking Prevention and Tobacco Control Act of 2009 gave the U.S. Food and Drug Administration the authority to regulate tobacco products, the agency has authorized the marketing of two new tobacco products and denied the marketing of four others through the substantial equivalence (SE) pathway..."

http://www.nytimes.com/2013/06/26/health/fda-begins-regulating-tobacco-products.html

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 join our network

[DIV28_ANNOUNCEMENT] Congratulations to 2015 Division 28 Election Winner Bill Stoops!

I am pleased to announce the election of William W. Stoops of the University of Kentucky College of Medicine as Division 28’s 2015 President. Bill is an exceptionally productive behavioral pharmacologist who has been honored by the Division three times in the past seven years. He was the recipient of the Outstanding Dissertation Award in 2006, the Wyeth Young Psychopharmacologist Award in 2008, and was elected to the ranks of Division Fellows in 2012. This month, he received the 2013 Joseph Cochin Young Investigator Award from the College on Problems of Drug Dependence. In addition to his research accomplishments in the field of psychopharmacology, Bill has shown commitment to our Division throughout his career, having served as Newsletter Editor, then as Division Secretary. Bill brings a fresh perspective to our Division, and we are fortunate to have his leadership in 2015. Congratulations, Bill!

 

 

 

Anthony Liguori, PhD
President, Division 28

Department of Physiology and Pharmacology
Medical Center Boulevard  \  Winston-Salem, NC 27157
p 336.716.8543  \  f 336.716.8501
aliguori@wakehealth.edu  \  WakeHealth.edu

 

 

 

[DIV28SUPER] Fwd: [CPDD] Dr. William L. Woolverton

Sent from my iPhone

Begin forwarded message:

From: Scott F Coffey <SCoffey@UMC.EDU>
Date: June 14, 2013, 6:01:00 PM EDT
To: "CPDD@LISTS.VCU.EDU" <CPDD@LISTS.VCU.EDU>
Subject: [CPDD] Dr. William L. Woolverton
Reply-To: Scott F Coffey <SCoffey@UMC.EDU>

Dear Colleagues,

I regret to inform you that Dr. William L. Woolverton, Billy S. Guyton Distinguished Professor and Vice Chair for Research in the Department of Psychiatry and Human Behavior died on June 13, 2013 after a brief illness.

An Alabama native, Dr. Woolverton attended the University of the South, graduating Phi Beta Kappa in 1972 with an Bachelor of Arts degree in biology. He then attended graduate school at the University of Chicago studying pharmacology under the mentorship of Dr. Charles R. Schuster; graduating with a PhD in 1977. He completed postdoctoral training with Dr. Bob Balster in the Department of Pharmacology at the Medical College of Virginia. In 1980, he returned to the University of Chicago rising to the rank of Associate Professor. Dr. Woolverton arrived at the University of Mississippi Medical Center in June, 1993 at the rank of Professor and served as Vice Chair for Research in the Department of Psychiatry and Human Behavior for over a decade.

 

Dr. Woolverton was very active in the College on Problems of Drug Dependence, serving on the Board of Directors from 1997 to 2001. He also served as Secretary and the President of the International Study Group Investigating Drugs as Reinforcers. Dr. Woolverton was consistently funded by the National Institute on Drug Abuse and conducted outstanding neurobiological and behavioral research during his career.  He was a gifted mentor, training dozens of graduate students, postdoctoral associates, and junior faculty members.  He was also an outstanding and dedicated teacher of residents, medical students, and graduate students. 

Dr. Woolverton was a colleague of exceptional vision.  In 1994, he served as the first Director of the Division of Neurobiology and Behavior Research, which he guided in its early development.  He also served as the chair of the Steering Committee of the Program in Neuroscience, again, helping to guide a new training program in its early development.

Bill was a dear friend, colleague, and mentor with a wonderful dry sense of humor who will be greatly missed.  He is survived by his wife, Candy, his son, Chris, and his daughter, Lucy.

 

A memorial service will be held at Wright & Ferguson at 1161 Highland Colony Parkway, Ridgeland, MS 39157 at 4-6pm on Sunday, June 16. 

 

 

 

Scott F. Coffey, Ph.D.

Professor and Director, Division of Psychology

Department of Psychiatry and Human Behavior

The University of Mississippi Medical Center

2500 North State St.

Jackson, MS 39216

601-815-5588

scoffey@umc.edu

Addiction Research and Treatment Laboratory (ARTLab)

http://www.umc.edu/Education/Schools/Medicine/Clinical_Science/Psychiatry/Psychology/ART_Lab.aspx 

 

Individuals who have received this information in error or are not authorized to receive it must promptly return or dispose of the information and notify the sender. Those individuals are hereby notified that they are strictly prohibited from reviewing, forwarding, printing, copying, distributing or using this information in any way.

___________________________ CPDD@lists.vcu.edu moderated member announcements
College on Problems of Drug Dependence web site CPDDblog list archives
Enable CPDD-talk, a discussion list for: existing members new members
Click to signoff or signoff by email

[DIV28SUPER] NYTimes: E-Cigarettes Are in Vogue and at a Crossroads

From The New York Times:

E-Cigarettes Are in Vogue and at a Crossroads

The devices that mimic tobacco cigarettes are growing in popularity even as regulators in Europe and the United States weigh their risks.

http://nyti.ms/19rwVUy


Sent from my iPad
___________________ div28SUPER@lists.apa.org _____________________
Div28m members may post here subscribers corner: http://lists.apa.org

[DIV28M] Tobacco Regulatory Workshop at CPDD

Good afternoon- might I please distribute this notice to the APA
Division 28 listserv?
Warm regards,
Stacey Sigmon

********

Dear colleagues,

We are inviting you to attend the following College on Problems of
Drug Dependence Workshop:

Workshop XIII
NOVEL TOBACCO AND NICOTINE PRODUCTS AND REGULATORY SCIENCE
Chairs: Dorothy Hatsukami and Stacey C. Sigmon
Tuesday, June 18
8:00 - 10:00 PM
INDIGO E 202

The Family Smoking Prevention and Tobacco Control Act and regulatory science
David Ashley, FDA, Rockville, MD

Emerging tobacco products: Perils and potential promise
Jack Henningfield, Pinney Associates, Bethesda, MD

Regulatory science: Contributions from drug abuse researchers
Lawrence Carter, University of Arkansas for Medical Sciences, College
of Medicine, Little Rock, AR

Discussant
David Shurtleff, National Institute on Drug

Description: The tobacco market is evolving with the availability of
a plethora of new tobacco and nicotine products of varying types and
degrees of abuse liability and harm. These products range from oral
tobacco products to electronic nicotine delivery cigarettes to pure
nicotine inhalation devices. These products are advertised for use in
situations when a smoker cannot smoke or as a product to use instead
of cigarettes. As a result, the distinction between a product to be
used for recreational purposes and for cessation is becoming blurred.
The major challenge is determining how best to evaluate and regulate
these products. The goal of this symposium is to describe the current
Family Smoking Prevention and Tobacco Control Act, the current and
future tobacco/nicotine market, the research priorities of the FDA
Center for Tobacco Products and how CPDD researchers can contribute to
tobacco regulatory science.


Dorothy K. Hatsukami, Ph.D.
Forster Family Professor in Cancer Prevention
Professor of Psychiatry
University of Minnesota
717 Delaware St. SE
Minneapolis, MN 55414
Phone: 612 626-2121
Fax: 612 624-4610
Email: hatsu001@umn.edu


Stacey Sigmon, Ph.D.
University of Vermont
Department of Psychiatry
UHC-SATC, Room 1415
1 S. Prospect Street
Burlington, VT 05401
Phone: (802) 656-9987
Fax: (802) 656-5793
Email: stacey.sigmon@uvm.edu

__________________ Div28m@lists.apa.org ___________________
restricted to APA members subscribers corner: http://lists.apa.org

[DIV28SUPER] Tobacco Regulatory Workshop at CPDD

Good afternoon- might I please distribute this notice to the APA
Division 28 listserv?
Warm regards,
Stacey Sigmon

********

Dear colleagues,

We are inviting you to attend the following College on Problems of
Drug Dependence Workshop:

Workshop XIII
NOVEL TOBACCO AND NICOTINE PRODUCTS AND REGULATORY SCIENCE
Chairs: Dorothy Hatsukami and Stacey C. Sigmon
Tuesday, June 18
8:00 - 10:00 PM
INDIGO E 202

The Family Smoking Prevention and Tobacco Control Act and regulatory science
David Ashley, FDA, Rockville, MD

Emerging tobacco products: Perils and potential promise
Jack Henningfield, Pinney Associates, Bethesda, MD

Regulatory science: Contributions from drug abuse researchers
Lawrence Carter, University of Arkansas for Medical Sciences, College
of Medicine, Little Rock, AR

Discussant
David Shurtleff, National Institute on Drug

Description: The tobacco market is evolving with the availability of
a plethora of new tobacco and nicotine products of varying types and
degrees of abuse liability and harm. These products range from oral
tobacco products to electronic nicotine delivery cigarettes to pure
nicotine inhalation devices. These products are advertised for use in
situations when a smoker cannot smoke or as a product to use instead
of cigarettes. As a result, the distinction between a product to be
used for recreational purposes and for cessation is becoming blurred.
The major challenge is determining how best to evaluate and regulate
these products. The goal of this symposium is to describe the current
Family Smoking Prevention and Tobacco Control Act, the current and
future tobacco/nicotine market, the research priorities of the FDA
Center for Tobacco Products and how CPDD researchers can contribute to
tobacco regulatory science.


Dorothy K. Hatsukami, Ph.D.
Forster Family Professor in Cancer Prevention
Professor of Psychiatry
University of Minnesota
717 Delaware St. SE
Minneapolis, MN 55414
Phone: 612 626-2121
Fax: 612 624-4610
Email: hatsu001@umn.edu


Stacey Sigmon, Ph.D.
University of Vermont
Department of Psychiatry
UHC-SATC, Room 1415
1 S. Prospect Street
Burlington, VT 05401
Phone: (802) 656-9987
Fax: (802) 656-5793
Email: stacey.sigmon@uvm.edu

___________________ div28SUPER@lists.apa.org _____________________
Div28m members may post here subscribers corner: http://lists.apa.org

[DIV28SUPER] Fellowship in Addiction Treatment

The VA San Diego Healthcare System is one of seven sites selected for a VA-funded Interprofessional Advanced Fellowship in Addiction Treatment. Our two-year advanced fellowship will recruit physicians and clinical/counseling psychologists. The plan is to recruit one board eligible or board certified physician and one clinical/counseling psychologist each year, with our first class starting September 1, 2013. Advanced Fellows must demonstrate interest in pursuing VA careers with addiction treatment as a significant focus. Fellows will spend at least 75 percent of their time in educational experiences and clinical research in addiction treatment. No more than 25% of fellow effort shall be for non-educational clinical service. Faculty research mentors include Drs. Shannon Robinson and Tamara Wall (Co-Directors), Abigail Angkaw, Robert Anthenelli, Sandra Brown, Neal Doran, Eric Granholm, Igor Grant, Scott Matthews, Mark Myers, Sonya Norman, Martin Paulus, Carmen Pulido, Marc Schuckit, Andrea Spadoni, Susan Tapert, Susan Tate, Steven Thorp, and Ryan Trim.

 

Application: Please submit a letter of interest (maximum 2 pages), CV, and the names of three references. The letter of interest should include: a brief summary of educational, clinical and research experiences relevant to addictions and a statement of career goals, including research mentor(s) with whom you might be interested in working. Materials should be submitted by email to vafellowship@ucsd.edu. The preferred application deadline is July 1, 2013, but positions will remain open until filled.

 

Qualifications: The following are required for physicians: 1) completion of an ACGME accredited residency program, 2) a full and unrestricted license to practice in the U.S. or any of its territories, 3) be board certified or eligible with demonstration of active pursuit of board certification, 4) U.S. citizenship, and 5) if a graduate of a foreign medical school, must have evidence of ECFMG certification. The following are required for psychologists: 1) completion of an APA-accredited doctorate in clinical or counseling psychology and an APA-accredited clinical psychology internship by September 1, 2013, and 2) U.S. citizenship.

[DIV28SUPER] Postdoc position in human hallucinogen research at Johns Hopkins

Dear Div. 28 members and affiliates,

Please let members of your research group know of this Postdoctoral Fellowship research opportunity in human hallucinogen pharmacology at Johns Hopkins. A flyer for printing and posting is attached.

Thanks,

Matt

 

HUMAN HALLUCINOGEN RESEARCH AT JOHNS HOPKINS

 

Postdoctoral research fellowship available immediately in a stimulating, productive research program with excellent resources. Prepare as independent investigator.  Position supported by a NIDA T32 postdoctoral training grant.

Human Laboratory: Behavioral and clinical pharmacology of abused hallucinogens (including DMT, psilocybin, salvinorin A, and dextromethorphan) examining abuse liability, self-administration, cognitive function, perceptual effects, and neuroimaging.

Eligibility: U.S. citizen, permanent resident.  A broad range of backgrounds are appropriate – from clinical/counseling to experimental/neuroscience.

NIH stipend levels: $39K - 54K+

Start Date: Flexible but available immediately

Contact Roland Griffiths or Matthew Johnson, BPRU, Behavioral Biology Research Center, 5510 Nathan Shock Drive, Johns Hopkins School of Medicine, Baltimore, Maryland 21224-6823. Griffiths: (410) 550-0034, rgriff@jhmi.edu; Johnson: (410) 550-0056, mwj@jhu.edu. See http://www.hopkinsmedicine.org/psychiatry/research/BPRU/

 

--
Matthew W. Johnson, Ph.D.
Associate Professor
Behavioral Pharmacology Research Unit
Department of Psychiatry and Behavioral Sciences
Johns Hopkins University School of Medicine
5510 Nathan Shock Drive
Baltimore, MD  21224-6823
Tel: 410-550-0056
Fax: 410-550-0030
Email: mwj@jhu.edu

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 join our network